JHJianmin Hu

Jianmin Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianmin Hu has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Yang Yu

    Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University

    10 shared publications
  • Shu Lin

    Group of Neuroendocrinology, Garvan Institute of Medical Research, Sydney, Australia

    5 shared publications
  • Ting Chen

    Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China

    4 shared publications
  • Zihao Zhuang

    Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University

    4 shared publications
  • Jianqing Zheng

    Fujian Province University Engineering Research Center of Assistive Technology for Visual Impairment, Quanzhou, China

    3 shared publications
  • Licheng Li

    Department of Ophthalmology, the Second Affiliated Hospital of Fujian Medical University, Engineering Research Centre of Assistive Technology for Visual Impairment, Fujian Province University, Quanzhou, Fujian, China

    3 shared publications

Latest Publications

  • Open Access

    Genetic susceptibility and clinical validation of ICAM-5 in immune-mediated non-infectious uveitis

    by Zihao Zhuang, Pengcheng Hu, Xuanming Hong, Tianfeng Lin, Yang Yu, Xinyu Jia, Xuemei Su, Binling Su, Wenjian Shi, Jianmin Hu

    Purpose: To investigate genetically supported molecular factors associated with uveitis and to evaluate the clinical, transcriptomic, and retinal relevance of intercellular adhesion molecule 5 (ICAM-5) across major immune-mediated non-infectious uveitis subtypes. Methods: Two-sample Mendelian randomization (MR) was conducted using eQTLGen eQTL data and two independent pQTL resources (Icelandic SomaScan and FinnGen R10), with uveitis GWAS summary statistics as the outcome. ICAM5 was evaluated using complementary MR estimators, sensitivity analyses, reverse MR, and Bayesian colocalization. Plasma ICAM-5 concentrations were measured by ELISA in 90 patients with active non-infectious uveitis (30 each with Vogt-Koyanagi-Harada disease, Behçet’s disease-associated uveitis, and HLA-B27-associated acute anterior uveitis) and 40 healthy controls using age- and sex-adjusted models. ICAM5 expression was further examined in the peripheral-blood transcriptomic dataset GSE194060, whereas retinal Icam5 expression and cellular distribution were evaluated using experimental autoimmune uveitis retinal single-cell RNA-sequencing data and GSE132229. Results: Genetically predicted higher ICAM5 expression and ICAM-5 protein levels were associated with increased uveitis susceptibility in the eQTLGen dataset (OR = 2.46, 95% CI 1.48–4.11, P = 5.69 × 10 -4 ; nSNP =8), the Icelandic SomaScan cis-pQTL analysis (OR = 1.27, 95% CI 1.11–1.46, P = 5.30 × 10 -4 ; nSNP =89), and the FinnGen R10 cis-pQTL analysis (OR = 1.21, 95% CI 1.07–1.38, P = 3.13 × 10 - ³; nSNP =4). Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy, and reverse MR provided no evidence of an association from uveitis liability to ICAM-5 levels. Plasma ICAM-5 concentrations were higher in all three uveitis subgroups than in healthy controls and remained elevated after age and sex adjustment, with the greatest increase in Vogt-Koyanagi-Harada disease. In the GSE194060 peripheral-blood transcriptomic dataset, ICAM5 expression was higher in the uveitis group. Analysis of the retinal single-cell RNA-sequencing data showed that Icam5 was predominantly detected in neuronal populations. Conclusion: Multi-omics MR, clinical protein quantification, transcriptomic analysis, and retinal single-cell profiling provide convergent evidence linking ICAM-5 to immune-mediated non-infectious uveitis. These findings support ICAM-5 as a genetically supported candidate mediator and circulating biomarker.

  • Open Access

    TREM2 Regulates Microglial Activation via the ERK/p38 Signaling Pathway: Implications for the Pathogenesis of Experimental Autoimmune Uveitis

    by Yang Yu, Xuemei Su, Zihao Zhuang, Pengcheng Hu, Mingjia Wang, Zhikang Liao, Peizeng Yang, Jianmin Hu

    The purpose of this study was to investigate the role of the trigger receptor expressed on myeloid cell 2 (TREM2) in experimental autoimmune uveitis (EAU) and elucidate the mechanisms by which TREM2 modulated inflammation and microglial activation via key signaling pathways. EAU mouse models and microglial cell BV2 inflammation models were established to explore TREM2 function. TREM2 expression in EAU retinas was detected using public databases and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). RT-qPCR, Western blotting, enzyme-linked immunosorbent assay (ELISA), and flow cytometry assessed TREM2 functional phenotypes in autoimmune uveitis. Western blotting and RNA sequencing (RNA-seq) analyzed key signaling pathways' activation to clarify TREM2's molecular mechanisms of inflammatory regulation. TREM2 expression in EAU was elevated at inflammatory peak and reduced during resolution. TREM2 knockdown in inflamed microglia exacerbated inflammation, whereas overexpression alleviated it. TREM2 knockout in EAU mice enhanced retinal vascular leakage, elevated splenic Th1 and Th17 cell proportions, and reduced Treg cell proportions. TREM2 knockdown promoted phosphorylated ERK/p38 activation; overexpression suppressed it. RNA-seq revealed altered retinal mRNA profiles in TREM2 knockout EAU mice, with activation of ERK/p38-associated pathways including the mitogen-activated protein kinase (MAPK) pathway. TREM2 exerted an anti-inflammatory role in EAU pathogenesis, likely by regulating microglial activation and inhibiting the ERK/p38 signaling pathway in these cells.


  • Open Access

    Development of a machine learning model to predict low vision aid fitting for visually impaired patients

    by Bingfa Dai, Pengpeng Pei, Zunqi Kan, Hai Lan, Wenwen Ye, Yang Yu, Xuelan Chen, Yuyuan Yan, Ting Chen, Jianqing Zheng, et al.

    Background: At present, the fitting of low-vision aids (LVA) for patients globally necessitates the intervention of highly skilled ophthalmologists and certified rehabilitation specialists. To mitigate this limitation, we employed machine learning algorithms to develop an artificial intelligence (AI)-based model for automated LVA fitting assistance. Patients and Methods: Clinical characteristics and diagnostic data from patients with low vision in southeastern China were collected between October 26, 2015, and October 6, 2021, to establish the training and test datasets. We developed and compared three machine learning models—Random Forest (RF), Deep Neural Network (DNN), and Logistic Regression (LR)—to predict prescriptions for three LVA categories selected based on compliance with the World Health Organization's basic specifications for assistive products: Distant Optical Visual aids (DOV), Near Electronic Visual aids (NEV), and Near Optical Visual aids (NOV). Hyperparameter optimization was conducted through four rounds of internal cross-validation. Following model training, the best-performing model was identified and subsequently validated on external data to assess its predictive accuracy and sensitivity. Results: The dataset comprised a total of 1,241 patients diagnosed with low vision. Our model displayed satisfactory performance in LVA fitting when evaluated on the test set. Comparative analysis revealed the RF model as the optimal choice, achieving area under the curve (AUC) values of 0.93 for DOV, 0.83 for NEV, and 0.91 for NOV. Furthermore, feature importance analysis derived from the RF model weights indicated that patient age, best-corrected visual acuity (BCVA of the left eye), and consultation year were the predominant factors influencing LVA fitting decisions across all three aid categories, while visual disability grade specifically impacted DOV prescriptions. In external validation involving 112 prospective cases, the model demonstrated performance comparable to that of a mid-career ophthalmologist (5 years' experience). Conclusion: This study identified significant associations between clinical characteristics and LVA prescription patterns. Leveraging historical LVA fitting data, we developed a machine learning-based decision support system capable of predicting optimal fittings for the three fundamental LVA categories. The proposed tool demonstrates potential for clinical application by generating data-driven prescription recommendations.


  • Open Access

    Targeting MicroRNA in myopia: Current insights

    by Zihao Zhuang, Licheng Li, Yang Yu, Xuemei Su, Shu Lin, Jianmin Hu


  • Open Access

    Dopamine Receptor 1 Treatment Promotes Epithelial Repair of Corneal Injury by Inhibiting NOD-Like Receptor Protein 3–Associated Inflammation

    by Licheng Li, Yang Yu, Zihao Zhuang, Qi Wu, Shu Lin, Jianmin Hu

    Purpose: To elucidate the influence of dopamine receptor 1 (DRD1) on the proliferation of mouse corneal epithelial cells (MCECs) under inflammatory conditions. Methods: In vitro, immortalized MCECs (iMCECs) were treated with IL-1β, with and without pcDNA3.1_DRD1. Primary MCECs (pMCECs) were exposed to IL-1β, with and without DRD1 agonist (A68930). Cell proliferation was quantified using the Cell Counting Kit-8 (CCK-8) assay and immunofluorescence staining for Ki-67 and p63. Expression levels of NOD-like receptor protein 3 (NLRP3), IL-1β, and IL-6 were assessed. To establish a corneal injury model in mice, a 2-mm superficial keratectomy was performed. Either 0.1% A68930 or PBS was topically administered three times daily to the injured eyes for up to 5 days post-injury. Immunofluorescence analysis was employed to evaluate the expression of Ki-67, p63, and CD45 in mouse corneas. Western blotting and real-time quantitative PCR were utilized for quantitative analysis of DRD1, NLRP3, IL-1β, and IL-6 in mouse corneas. Corneal epithelial regeneration was monitored through fluorescein sodium staining for a duration of up to 5 days following the injury. Results: Overexpression of DRD1 and A68930 promoted MCEC proliferation and suppressed the expression of NLRP3, IL-1β, and IL-6 in vitro. Topical application of the 0.1% A68930 following mechanical corneal injury in mice led to increased Ki-67 and p63 expression compared to PBS treatment. Furthermore, topical administration of the 0.1% A68930 reduced the expression of CD45, NLRP3, IL-1β, and IL-6. Analysis with fluorescein sodium indicated accelerated corneal epithelial regeneration in the 0.1% A68930 treatment group. Conclusions: DRD1 treatment counteracts NLRP3-associated inflammation and facilitates epithelial repair of corneal injury.


  • Circadian rhythm, ipRGCs, and dopamine signalling in myopia

    by Licheng Li, Yang Yu, Zihao Zhuang, Qi Wu, Shu Lin, Jianmin Hu

    Myopia, a common ophthalmic disorder, places a high economic burden on individuals and society. Genetic and environmental factors influence myopia progression; however, the underlying mechanisms remain unelucidated. This paper reviews recent advances in circadian rhythm, intrinsically photosensitive retinal ganglion cells (ipRGCs), and dopamine (DA) signalling in myopia and proposes the hypothesis of a circadian rhythm brain retinal circuit in myopia progression. The search of relevant English articles was conducted in the PubMed databases until June 2023. Based on the search, emerging evidence indicated that circadian rhythm was associated with myopia, including circadian genes Bmal1, Cycle, and Per. In both humans and animals, the ocular morphology and physiology show rhythmic oscillations. Theoretically, such ocular rhythms are regulated locally and indirectly via the suprachiasmatic nucleus, which receives signal from the ipRGCs. Compared with the conventional retinal ganglion cells, ipRGCs can sense the presence of light because of specific expression of melanopsin. Light, together with ipRGCs and DA signalling, plays a crucial role in both circadian rhythm and myopia. In summary, regarding myopia progression, a circadian rhythm brain retinal circuit involving ipRGCs and DA signalling has not been well established. However, based on the relationship between circadian rhythm, ipRGCs, and DA signalling in myopia, we hypothesised a circadian rhythm brain retinal circuit.


  • Improving myopia awareness via school-based myopia prevention health education among Chinese students

    by Luo-Ming Huang, Xian-Ming Fan, Yu-Hong Xie, Zhi-Yong Meng, Ting Chen, Bing-Fa Dai, Yang Yu, Zhen Zeng, Chun-Ya Zhou, Jia-Jia Lin, et al.

    AIM: To investigate the myopia awareness level, knowledge, attitude, and skills at baseline and to implement and evaluate the efficacy of myopia prevention health education among Chinese students. METHODS: A total of 1000 middle school students from 2 middle schools were invited to participate in the study, and myopia prevention health education was conducted. The students were assessed at baseline, followed by a survey. The efficacy of health education was evaluated using the self-comparison method pre- and post-health education. RESULTS: The study included 957 and 850 pre- and post-health education participants, respectively. The baseline knowledge of all respondents on myopic symptoms (87.5%), myopia is a risk of eyes (72.9%), myopia prevention (91.3%), myopia increases with age (86.7%), performing periodic eye examinations (92.8%), and one first, one foot, and one inch (84.8%) significantly increased after health education (P<0.001 for all). However, the percentage of students who still did not think it necessary to take breaks after 30-40min of continuous near work was 27.0%. The opinion that “myopia can be cured” was still present in 38.3%. CONCLUSION: Implementing school-based myopia prevention health education improves knowledge, attitudes, and skills regarding myopia among Chinese middle school students.


  • Open Access

    Genetic association of PRKCD and CARD9 polymorphisms with Vogt–Koyanagi–Harada disease in the Chinese Han population

    by Chunya Zhou, Shiya Cai, Yuhong Xie, Zhen Zeng, Jun Zhang, Guannan Su, Qiuying Wu, Xingsheng Ye, Qingfeng Cao, Peizeng Yang, et al.

    Background: Protein kinase C delta (PRKCD) and caspase recruitment domain family member 9 (CARD9) are genes involved in B and T cell activation, and cytokine production, which are vital mechanisms underlying autoimmune disease development. This study aimed to explore the association of the PRKCD and CARD9 genes with Vogt–Koyanagi–Harada disease (VKH) disease. The case–control study was performed to in 912 patients with VKH and 878 normal controls. MassARRAY system, SHEsis online platform, real-time PCR, and enzyme-linked immunosorbent assay were used to detect genotyping, haplotyping, mRNA expression, and cytokine levels, respectively. Results: We found that rs74437127 C allele of PRKCD, rs3812555 CC genotype, and C allele of CARD9 were associated with increased susceptibility of VKH (Pc = 0.020, OR = 1.624; Pc = 2.04 × 10–5, OR = 1.810; Pc = 2.76 × 10–5, OR = 1.698, respectively). However, the rs74437127 T allele, and rs3812555 TC genotype and T allele were linked with decreased susceptibility to VKH (Pc = 0.020, OR = 0.616; Pc = 7.85 × 10–5, OR = 0.559; Pc = 2.76 × 10–5, OR = 0.589, respectively). PRKCD ATG and CARD9 GCTTA haplotypes decreased susceptibility to VKH (Pc = 3.11 × 10–3, OR = 0.594; Pc = 5.00 × 10–3, OR = 0.639, respectively). Functional studies on rs3812555 genotyped individuals revealed that CC carriers had significantly higher CARD9 mRNA expression and tumour necrosis factor-α production than TC/TT carriers (P = 1.00 × 10–4; P = 2.00 × 10–3, respectively). Conclusions: We found an association between PRKCD rs74437127 and CARD9 rs3812555 polymorphisms and VKH susceptibility and revealed that the increased susceptibility of rs3812555 for VKH may be mediated by regulating CARD9 gene expression and the production of pro-inflammatory cytokines, such as TNF-α.


  • Open Access

    Association between sleep duration and myopia among Chinese children during the COVID-19 pandemic: A cross-sectional study

    by Luoming Huang, Xuelan Chen, Jiajia Lin, Xianming Fan, Ting Chen, Yang Yu, Jiaxin Chen, Jianmin Hu

    Background: The studies on the association between sleep duration and myopia are limited, and the evidence is inconsistent. This study aimed to evaluate the association between sleep duration and myopia, cycloplegic spherical equivalent (SE) and axial length (AL) among Chinese children during the Corona Virus Disease 2019 (COVID-19) pandemic.Methods: The study was a cross-sectional study on Chinese children aged 6–18 years. The comprehensive ophthalmic examinations for children included cycloplegic SE, AL, and standardized questionnaires. The questionnaire included sleep duration, parental myopia, outdoor time, and continuous near work duration without breaks. Myopia was defined as SE ≤-0.50 diopters (D).Results: A total of 1,140 children were included in the analyses, with 84.7% of myopic children and 74.4% of children's daily sleep duration being more than 8 h/d. In univariate regression analysis, compared with sleep duration < 8 h/d, children with sleep duration of 8–9 and >9 h/d were less myopia (p < 0.01 for all), and had less myopic SE (p < 0.01 for all), and shorter AL (p < 0.01 for all). After adjusting for age, gender, parental myopia, outdoor time, and continuous near work duration without breaks, sleep duration was not associated with myopia, cycloplegic SE, and AL (p > 0.05 for all).Conclusions: This study showed sleep duration was related to myopia, cycloplegic SE, and AL among Chinese children during the COVID-19 pandemic-related lifestyles, but no independent association.